Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.5%

2 terminated/withdrawn out of 81 trials

Success Rate

95.2%

+8.7% vs industry average

Late-Stage Pipeline

30%

24 trials in Phase 3/4

Results Transparency

0%

0 of 40 completed trials have results

Key Signals

8 recruiting

Enrollment Performance

Analytics

N/A
31(41.9%)
Phase 3
16(21.6%)
Phase 2
12(16.2%)
Phase 4
8(10.8%)
Phase 1
7(9.5%)
74Total
N/A(31)
Phase 3(16)
Phase 2(12)
Phase 4(8)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (81)

Showing 20 of 81 trials
NCT07436988Phase 1Not Yet Recruiting

Affordable Made-in-India Microspheres for Liver Cancer Therapy

Role: collaborator

NCT07445620Not ApplicableNot Yet Recruiting

Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant Schizophrenia

Role: collaborator

NCT07243704Phase 3Not Yet Recruiting

Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage

Role: collaborator

NCT05836831Phase 4Recruiting

Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage

Role: collaborator

NCT07131540Phase 1Not Yet Recruiting

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)

Role: collaborator

NCT07131280Not ApplicableNot Yet Recruiting

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated Cirrhosis

Role: collaborator

NCT07131306Phase 2Not Yet Recruiting

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial

Role: collaborator

NCT07075315Phase 3Not Yet Recruiting

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial

Role: collaborator

NCT07114094Not ApplicableRecruiting

Development, Validation and Evaluation of a Deprescribing Tool

Role: lead

NCT07072624Phase 4Recruiting

Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial)

Role: collaborator

NCT05732142Not ApplicableCompleted

Postpartum Integration of Vaccines and Contraception Trial

Role: collaborator

NCT06538077Phase 4Recruiting

BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE

Role: collaborator

NCT04157465Not ApplicableCompleted

Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients

Role: collaborator

NCT06431919Not ApplicableRecruiting

Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival

Role: collaborator

NCT06836661Not ApplicableNot Yet Recruiting

Impact, Cost, and Sustainability of a Customized, Low-Cost Intervention to Reduce Cardiovascular Disease Burden in India: A Cluster Randomized Trial

Role: collaborator

NCT06895252Not ApplicableRecruiting

A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis

Role: collaborator

NCT06890650Not ApplicableRecruiting

A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease

Role: collaborator

NCT06494124Not ApplicableRecruiting

Efficacy and Safety of tACS vs tDCS in Schizophrenia

Role: collaborator

NCT06377397Phase 3Not Yet Recruiting

Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates

Role: lead

NCT05917340Phase 3Not Yet Recruiting

Intensified Short Course Regimen for TBM in Adults

Role: lead